David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PXD
76
DELISTED
Pioneer Natural Resource Co.
PXD
| $164M | 0.25% |
1,113,123
+23,233
| +2% | +$3.34M |
|
77
CALL
Bank of America
BAC
$431B
| $163M | 0.25% |
6,448,600
+79,500
| +1% | +$1.93M |
|
78
Aramark
ARMK
$15.8B
| $163M | 0.25% |
5,559,760
+773,958
| +16% | +$22.5M |
|
79
Canadian Pacific Kansas City
CP
$85B
| $162M | 0.25% |
4,826,055
+1,133,800
| +31% | +$36.1M |
|
80
PUT
Intuitive Surgical
ISRG
$134B
| $155M | 0.24% |
1,331,100
+450,000
| +51% | +$49M |
|
|
RICE
81
DELISTED
Rice Energy Inc.
RICE
| $154M | 0.24% |
5,310,135
+448,448
| +9% | +$12.3M |
|
82
Bristol-Myers Squibb
BMY
$137B
| $153M | 0.23% |
2,397,250
-1,246,288
| -34% | -$72.8M |
|
83
PUT
Netflix
NFLX
$331B
| $152M | 0.23% |
8,375,000
+4,416,000
| +112% | +$77M |
|
|
84
PUT
Gilead Sciences
GILD
$181B
| $151M | 0.23% |
1,864,400
-48,400
| -3% | -$3.7M |
|
85
PUT
Apple
AAPL
$4.51T
| $146M | 0.22% |
3,799,600
+783,600
| +26% | +$30.4M |
|
86
Halliburton
HAL
$29.4B
| $146M | 0.22% |
3,178,040
-1,086,605
| -25% | -$45.5M |
|
87
CALL
Citigroup
C
$221B
| $145M | 0.22% |
1,989,700
+376,700
| +23% | +$25.7M |
|
88
ExxonMobil
XOM
$679B
| $144M | 0.22% |
1,762,509
+1,207,751
| +218% | +$95.9M |
|
89
Lam Research
LRCX
$393B
| $143M | 0.22% |
7,745,060
-4,955,740
| -39% | -$80.4M |
|
90
British American Tobacco
BTI
$121B
| $142M | 0.22% |
2,278,894
+2,230,658
| +4,624% | +$144M |
|
91
Amazon
AMZN
$2.79T
| $142M | 0.22% |
2,955,020
+1,273,580
| +76% | +$62.6M |
|
|
CLGX
92
DELISTED
Corelogic, Inc.
CLGX
| $142M | 0.22% |
3,070,633
-202,379
| -6% | -$9.19M |
|
|
VMW
93
DELISTED
VMware, Inc
VMW
| $141M | 0.22% |
1,291,723
-96,209
| -7% | -$9.5M |
|
94
Kraft Heinz
KHC
$30.3B
| $140M | 0.22% |
1,810,903
+977,978
| +117% | +$81.8M |
|
95
CALL
Meta Platforms (Facebook)
META
$1.4T
| $140M | 0.22% |
820,000
-38,400
| -4% | -$6.41M |
|
96
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $139M | 0.21% |
1,191,919
+143,000
| +14% | +$16.5M |
|
|
LBRDA
97
DELISTED
Liberty Broadband Class A
LBRDA
| $139M | 0.21% |
1,471,206
+66,053
| +5% | +$6.3M |
|
98
Lamb Weston
LW
$7.38B
| $137M | 0.21% |
2,929,935
+26,713
| +0.9% | +$1.2M |
|
99
Analog Devices
ADI
$182B
| $137M | 0.21% |
1,588,047
+13,835
| +0.9% | +$1.12M |
|
100
Danaher
DHR
$154B
| $136M | 0.21% |
1,791,423
+815,332
| +84% | +$60.3M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.